Chinese CDMO contracted to manufacture Pfizer’s oncology candidate
CMAB Biopharma to support Kintor in the clinical development of a potential treatment for liver cancer, ahead of regulatory filing.
Archives for August 27, 2019
UPDATED
Biocon insulin facility in Malaysia passes EU inspection
Asia’s largest integrated insulins facility, operated by a subsidiary of Biocon in Malaysia, receives GMP compliance certification from Ireland’s HPRA.